Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 3/20 | 0.44 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17065250 | 0.83 | RAB9A (0.36) | ALDH1A1 | |
| SCHEMBL17045814 | 0.79 | KMT2A (0.43) | KMT2ALMNAHTTCXCR4ALDH1A1 | |
| SCHEMBL775430 | 0.78 | KDM4E (0.36) | KMT2AHTTALDH1A1KDM4EMEN1 | |
| SCHEMBL16176982 | 0.78 | LPL (0.36) | KMT2ALMNAHTTALDH1A1ALOX15 | |
| SCHEMBL26621923 | 0.76 | LPL (0.41) | KMT2ALMNAHTTALDH1A1KDM4E | |
| SCHEMBL12822400 | 0.76 | MEN1 (0.41) | KMT2AALDH1A1KDM4EMEN1GAA | |
| SCHEMBL12822237 | 0.76 | NFKB1 (0.40) | KMT2AALDH1A1KDM4EL3MBTL1MEN1 | |
| SCHEMBL775018 | 0.75 | LPL (0.40) | KMT2ALMNAALDH1A1KDM4EGAA | |
| SCHEMBL18662581 | 0.75 | LPL (0.40) | KMT2ALMNAALDH1A1KDM4EGAA | |
| SCHEMBL774936 | 0.75 | ALDH1A1 (0.41) | KMT2ALMNAHTTALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108137730-B | Polymerization process using pyridyldiamido compound supported on organoaluminum-treated layered silicate support | 埃克森美孚化学专利公司 | 2021-10-29 | — | — | CN | disclosed |
| US-10676547-B2 | Aluminum alkyls with pendant olefins on clays | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-06-09 | — | — | US | disclosed |
| US-20180201700-A1 | Aluminum Alkyls with Pendant Olefins on Clays | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-07-19 | — | — | US | disclosed |
| EP-3344385-A1 | ALUMINUM ALKYLS WITH PENDANT OLEFINS ON CLAYS | ExxonMobil Chemical Patents Inc. (US) | 2018-07-11 | — | — | EP | disclosed |
| US-9982067-B2 | Polymerization process using pyridyldiamido compounds supported on organoaluminum treated layered silicate supports | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-05-29 | — | — | US | disclosed |
| US-20170088641-A1 | Polymerization Process Using Pyridyldiamido Compounds Supported on Organoaluminum Treated Layered Silicate Supports | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-03-30 | — | — | US | disclosed |
| WO-2017039994-A1 | ALUMINUM ALKYLS WITH PENDANT OLEFINS ON CLAYS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-03-09 | — | — | WO | disclosed |
| EP-3114130-A1 | PYRIDYLDIAMIDO TRANSITION METAL COMPLEXES, PRODUCTION AND USE THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2017-01-11 | — | — | EP | disclosed |
| US-9315526-B2 | Pyridyldiamido transition metal complexes, production and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-04-19 | — | — | US | disclosed |
| WO-2015134213-A1 | PYRIDYLDIAMIDO TRANSITION METAL COMPLEXES, PRODUCTION AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-09-11 | — | — | WO | disclosed |
| US-20150246982-A1 | Pyridyldiamido Transition Metal Complexes, Production and Use Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2015-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150246982-A1 | Pyridyldiamido Transition Metal Complexes, Production and Use Thereof | PNPO, PARN, PPOX | KMT2A 3479/4885LMNA 1780/4885HTT 3867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.